EincoBio is a Brazilian company that has been pioneering since the end of the 1970s in the area of bioengineering for the repair, reconstitution and regeneration of organs, systems and living tissues, mainly bone, and business since 1985 (Junta Comercial / MG No. 31202212781). The Company combines specialized knowledge and high technology in the research and development of biosolutions, based on the principles of the organism, interacting naturally with substances and structures of the body itself. In fact, this is the great difference that makes its products - OSTEOSYNT, in innovative biosolutions recognized by the national / international scientific technical community as a world market reference in the reconstruction of bone tissues. They were also tailor made, with flexibility and speed to meet the needs of the doctor and the patient, they were the first products with these characteristics to be registered in Brazil and to have them regulated and regulated. EincoBio patented in 1991 (IPI 9104220-8 - 2nd patent) its materials, as well as the bone morphogenetic complex and its principles. In addition to producing and marketing OSTEOSYNT, EincoBio is a supplier of raw material for Biotechnology companies that develop complementary products and also makes licensing of products with specific brands. The group responsible for EincoBio maintains a strong presence in Biotechnology initiatives, through support and partnerships with renowned institutions in Brazil and abroad, helping to promote and consolidate the country's technological autonomy in Biotechnology. He founded the Brazilian Institute of Biomaterials - IBB (1990s) and the Latin American Society of Biomaterials and Artificial Organs - SLABO (1998) and introduced it to the National Biomaterials Forum.